Total Payments
$484.65
2022 Payments
$11.71
Companies
17
Transactions
32
Medicare Patients
2,371
Medicare Billing
$218,373
Payment Breakdown by Category
Food & Beverage$472.94 (97.6%)
Education$11.71 (2.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $472.94 | 31 | 97.6% |
| Education | $11.71 | 1 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $113.91 | 8 | $0 (2019) |
| Allergan, Inc. | $47.55 | 3 | $0 (2020) |
| Novo Nordisk Inc | $47.21 | 3 | $0 (2020) |
| Gilead Sciences Inc | $35.44 | 2 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $26.02 | 2 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $25.40 | 2 | $0 (2020) |
| Lilly USA, LLC | $24.18 | 2 | $0 (2022) |
| Adlon Therapeutics L.P. | $21.71 | 1 | $0 (2019) |
| Kaleo, Inc. | $18.80 | 1 | $0 (2019) |
| Rhodes Pharmaceuticals L.P. | $17.84 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $11.71 | 1 | Lilly USA, LLC ($11.71) |
| 2020 | $75.83 | 5 | Allergan, Inc. ($32.13) |
| 2019 | $161.68 | 10 | PFIZER INC. ($33.29) |
| 2018 | $171.15 | 12 | PFIZER INC. ($68.70) |
| 2017 | $64.28 | 4 | Gilead Sciences Inc ($35.44) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/28/2022 | Lilly USA, LLC | — | Education | In-kind items and services | $11.71 | General |
| 09/22/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS, Tresiba | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Diabetes | ||||||
| 01/24/2020 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: NEUROSCIENCE | ||||||
| 01/10/2020 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2019 | Ironshore Pharmaceuticals Inc. | Jornay PM 20mg capsules (Bottle of 100) (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Central nervous system (CNS) stimulant | ||||||
| 10/18/2019 | ASSERTIO THERAPEUTICS, Inc. | Cambia (Drug), Gralise, Zipsor | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Neurology | ||||||
| 08/30/2019 | Adlon Therapeutics L.P. | ADHANSIA XR (Drug) | Food and Beverage | Cash or cash equivalent | $21.71 | General |
| Category: PRESCRIPTION STIMULANT | ||||||
| 04/30/2019 | Merck Sharp & Dohme Corporation | ROTATEQ (Biological), PNEUMOVAX 23, VAQTA | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: VACCINE | ||||||
| 04/19/2019 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: ADHD | ||||||
| 04/09/2019 | Rhodes Pharmaceuticals L.P. | Aptensio XR (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Neurology | ||||||
| 04/06/2019 | PFIZER INC. | LYRICA (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 02/22/2019 | PFIZER INC. | LYRICA (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 01/07/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: Diabetes | ||||||
| 01/04/2019 | Kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: ALLERGY | ||||||
| 11/02/2018 | Lilly USA, LLC | BASAGLAR (Drug) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: Diabetes | ||||||
| 08/28/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: DIABETES | ||||||
| 08/14/2018 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Endocrinology | ||||||
| 08/14/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA, EUCRISA | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/20/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/11/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA, EUCRISA | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 04/09/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA, EUCRISA | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 03/23/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/27/2018 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 708 | 916 | $177,061 | $69,987 |
| 2022 | 13 | 619 | 763 | $142,150 | $57,695 |
| 2021 | 13 | 634 | 750 | $119,244 | $60,120 |
| 2020 | 10 | 410 | 483 | $71,763 | $30,571 |
Total Patients
2,371
Total Services
2,912
Medicare Billing
$218,373
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 170 | 279 | $69,750 | $22,438 | 32.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 166 | 166 | $37,308 | $20,405 | 54.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 152 | 222 | $39,960 | $11,714 | 29.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 12 | 12 | $5,964 | $3,395 | 56.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 43 | 43 | $5,289 | $3,093 | 58.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $4,180 | $2,205 | 52.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 12 | 14 | $4,962 | $2,166 | 43.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $3,630 | $1,729 | 47.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 50 | 52 | $2,931 | $1,489 | 50.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 26 | 26 | $1,324 | $744.38 | 56.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 35 | 60 | $1,440 | $571.20 | 39.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 17 | 17 | $323.00 | $37.40 | 11.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 133 | 133 | $26,866 | $16,580 | 61.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 144 | 209 | $52,250 | $16,435 | 31.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 127 | 186 | $33,480 | $10,095 | 30.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 23 | 25 | $8,500 | $2,860 | 33.6% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 11 | 11 | $4,290 | $2,772 | 64.6% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 12 | 14 | $4,620 | $2,200 | 47.6% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 35 | 35 | $2,030 | $1,991 | 98.1% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 14 | 14 | $1,680 | $1,654 | 98.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 36 | 36 | $1,476 | $982.28 | 66.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $4,680 | $972.60 | 20.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 25 | 25 | $875.00 | $684.27 | 78.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 30 | 45 | $1,080 | $431.64 | 40.0% |
| 81003 | Automated urinalysis test | Office | 2022 | 16 | 17 | $323.00 | $37.64 | 11.7% |
About Dr. Sarah Polito, DO
Dr. Sarah Polito, DO is a Family Medicine healthcare provider based in Valparaiso, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2014. The National Provider Identifier (NPI) number assigned to this provider is 1548675119.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sarah Polito, DO has received a total of $484.65 in payments from pharmaceutical and medical device companies, with $11.71 received in 2022. These payments were reported across 32 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($472.94).
As a Medicare-enrolled provider, Polito has provided services to 2,371 Medicare beneficiaries, totaling 2,912 services with total Medicare billing of $218,373. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Valparaiso, IN
- Active Since 06/23/2014
- Last Updated 09/15/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1548675119
Products in Payments
- CHANTIX (Drug) $44.65
- LYRICA (Drug) $33.29
- VRAYLAR (Drug) $32.13
- Ozempic (Drug) $30.29
- FARXIGA (Drug) $26.02
- PREVNAR - 13 (Biological) $22.72
- ADHANSIA XR (Drug) $21.71
- AUVI-Q (Drug) $18.80
- Aptensio XR (Drug) $17.84
- ClosureFast (Device) $17.04
- Synthroid (Drug) $16.96
- Saxenda (Drug) $16.92
- Cambia (Drug) $16.76
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $16.50
- BYSTOLIC (Drug) $15.42
- JARDIANCE (Drug) $14.54
- VYVANSE (Drug) $14.28
- ROTATEQ (Biological) $13.60
- CELEBREX (Drug) $13.25
- BASAGLAR (Drug) $12.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Valparaiso
Kenneth Blumenthal, Do, DO
Family Medicine — Payments: $29,294
Family Medicine $29,294
Dr. Christopher Osan, M.d, M.D
Family Medicine — Payments: $18,908
Family Medicine $18,908
Dr. Alyssa Pagliere Osan, M.d, M.D
Family Medicine — Payments: $17,476
Family Medicine $17,476
Dr. Arjun Gupta, Md, MD
Family Medicine — Payments: $3,030
Family Medicine $3,030
Janet Bilder, Do, DO
Family Medicine — Payments: $2,989
Family Medicine $2,989
Chike Okolocha, Do, DO
Family Medicine — Payments: $2,849
Family Medicine $2,849